Attendee - Fellowship Program Director Symposium [Non-CME]

Saturday, March 8, 2025

6:30 PM – 8:45 PM ET

Roundtable Participant(s)

Paul T. Campbell, MD

Interventional Cardiologist
Sanger Heart & Vascular Institute
Concord , North Carolina, United States

Disclosure(s): No financial relationships to disclose
James DeVries, MD

Director, Interventional Cardiology Fellowship Training Program
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States

Disclosure(s): No financial relationships to disclose
ME

Marvin Eng, MD

Structural Heart Disease Medical Director
Banner University Medical Center
Phoenix, Arizona, United States

Disclosure(s): Edwards Lifesciences LLC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Uzoma N. Ibebuogu, MD

Professor of Medicine
University of Tennessee
Memphis , Tennessee, United States

Disclosure(s): No financial relationships to disclose
Rony Lahoud, MD

Associate Professor
University of Vermont
S. Burlington, Vermont, United States

Disclosure(s): medtronic.: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Daniel S. Menees, MD

Director, Interventional Cardiology Fellowship Program
University of Michigan, Michigan, United States

Disclosure(s): No financial relationships to disclose
Bibhu D. Mohanty, MD

Associate Professor of Medicine
University of South Florida / Tampa General Hospital

Disclosure(s): Abbott Labs: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scietific: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consultant (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing), Grant/Research Support (Ongoing)
UR

Umamahesh C. Rangasetty, MD

Interventional cardiologist
University of Texas Medical branch at Galveston, Texas, United States

Disclosure(s): Abbott Cardiovascular Systems: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards, Medtronic, Boston Scientific: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Moderna: Stock-publicly held company (excluding mutual/index funds) (Terminated); Pfizer: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Philips-Spectranetics: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave Medical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Babak Azarbal, MD: No financial relationships to disclose

Paul T. Campbell, MD: No financial relationships to disclose

James DeVries, MD: No financial relationships to disclose

Ashequl M. Islam, MD: No financial relationships to disclose

Uzoma N. Ibebuogu, MD: No financial relationships to disclose

Daniel S. Menees, MD: No financial relationships to disclose

Bibhu D. Mohanty, MD: Abbott Labs: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scietific: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consultant (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing), Grant/Research Support (Ongoing)

Umamahesh C. Rangasetty, MD: Abbott Cardiovascular Systems: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards, Medtronic, Boston Scientific: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Moderna: Stock-publicly held company (excluding mutual/index funds) (Terminated); Pfizer: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Philips-Spectranetics: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave Medical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Daniel R. Schimmel, MD, MS: Abbott Vascular, Medtronic, Boston Scientific: Consultant (Terminated, November 1, 2023), Grant/Research Support (Terminated, November 1, 2023); Avnetus: Consultant (Ongoing), Grant/Research Support (Ongoing); Inari: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Penumbra, Inc.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)